BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/25/2021 9:46:23 AM | Browse: 345 | Download: 674
 |
Received |
|
2021-02-07 17:12 |
|
Peer-Review Started |
|
2021-02-07 17:16 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-04-05 17:08 |
|
Revised |
|
2021-04-07 16:51 |
|
Second Decision |
|
2021-05-27 11:35 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-05-27 12:18 |
|
Articles in Press |
|
2021-05-27 12:18 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-06-19 09:00 |
|
Publish the Manuscript Online |
|
2021-06-25 09:46 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Hepatitis delta virus: From infection to new therapeutic strategies
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Grazia A Niro, Arianna Ferro, Francesca Cicerchia, Isabella Brascugli and Marilena Durazzo |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Marilena Durazzo, MD, Associate Professor, Department of Medical Sciences, University of Turin, C So AM Dogliotti 14, Turin 10126, Italy. marilena.durazzo@unito.it |
| Key Words |
Hepatitis delta virus; Hepatitis B virus; Myrcludex; Lonafarnib; REP 2139 |
| Core Tip |
The hepatitis delta virus (HDV) is a small defective virus, of interest to scientists for its replicative reliance on and ability to inhibit the common hepatitis B virus (HBV). HDV infection occurs worldwide but shows some geographic variation and its prevalence is generally underestimated. HDV/HBV co-infection causes severe liver disease and the persistence of viral replication is associated with poor prognosis, although interferon is effective in around a quarter of patients. Improved understanding of the HDV life cycle has led to identification of specific antiviral targets and new drugs, including inhibitors of the sodium tauro-cholate cotransporting polypeptide receptor and farnesyltransferase. |
| Publish Date |
2021-06-25 09:46 |
| Citation |
Niro GA, Ferro A, Cicerchia F, Brascugli I, Durazzo M. Hepatitis delta virus: From infection to new therapeutic strategies. World J Gastroenterol 2021; 27(24): 3530-3542 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i24/3530.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i24.3530 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
